Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1191401.RA6FhsZZMHkHPUCyDrvVISvAiyDwzPbhOu3pjhM7ekgoc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1191401.RA6FhsZZMHkHPUCyDrvVISvAiyDwzPbhOu3pjhM7ekgoc130_assertion type Assertion NP1191401.RA6FhsZZMHkHPUCyDrvVISvAiyDwzPbhOu3pjhM7ekgoc130_head.
- NP1191401.RA6FhsZZMHkHPUCyDrvVISvAiyDwzPbhOu3pjhM7ekgoc130_assertion description "[Particularly, the mutational status and/or aberrant expression of certain markers, such as EGFR, HER2, cKIT, BRAF and AR, also identified in some tumor histotypes of the salivary glands, currently represent molecular targets for new and efficacious drugs routinely employed in the treatment of other neoplasias, such as breast, lungs, GIST and melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1191401.RA6FhsZZMHkHPUCyDrvVISvAiyDwzPbhOu3pjhM7ekgoc130_provenance.
- NP1191401.RA6FhsZZMHkHPUCyDrvVISvAiyDwzPbhOu3pjhM7ekgoc130_assertion evidence source_evidence_literature NP1191401.RA6FhsZZMHkHPUCyDrvVISvAiyDwzPbhOu3pjhM7ekgoc130_provenance.
- NP1191401.RA6FhsZZMHkHPUCyDrvVISvAiyDwzPbhOu3pjhM7ekgoc130_assertion SIO_000772 24923272 NP1191401.RA6FhsZZMHkHPUCyDrvVISvAiyDwzPbhOu3pjhM7ekgoc130_provenance.
- NP1191401.RA6FhsZZMHkHPUCyDrvVISvAiyDwzPbhOu3pjhM7ekgoc130_assertion wasDerivedFrom befree-2016 NP1191401.RA6FhsZZMHkHPUCyDrvVISvAiyDwzPbhOu3pjhM7ekgoc130_provenance.
- NP1191401.RA6FhsZZMHkHPUCyDrvVISvAiyDwzPbhOu3pjhM7ekgoc130_assertion wasGeneratedBy ECO_0000203 NP1191401.RA6FhsZZMHkHPUCyDrvVISvAiyDwzPbhOu3pjhM7ekgoc130_provenance.